title: Dopamine inhibits AVP-dependent Na+ transport and water permeability in rat CCD via a D4-like receptor.
abstract: We studied the receptor responsible for dopamine action in isolated perfused cortical collecting ducts (CCD) from rats treated with deoxy-corticosterone. (Critical experiments were repeated in CCD from untreated rats with the same results.) At doses > or = 1 microM, dopamine inhibited arginine vasopressin (AVP)-dependent Na+ and water transport (measured by the unidirectional lumen-to-bath 22Na+ flux and the transepithelial voltage) and osmotic water permeability (Pf). The effects of dopamine were not reversed by the dopamine-1 (D1) antagonist SCH-23390, and no inhibition was produced by the D1 agonists fenoldopam or SKF-81247. When Na+ transport and Pf were stimulated with 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate plus 3-isobutyl-1-methylxanthine, dopamine did not inhibit, suggesting a "D2-type" receptor. However, the D2 agonist quinpirole had no effect on the AVP-dependent transepithelial voltage (VT), and the D2 and D3 antagonists domperidone and pimozide did not reverse dopamine inhibition of VT. The only agent tested that reversed the effects of dopamine was the D4-specific antagonist clozapine. We conclude that dopamine inhibition of salt and water transport in the CCD is mediated by a D4-like receptor.
authors.affiliation: Department of Physiology, University of Alabama at Birmingham 35294, USA.
authors.forename: D
authors.initials: D
authors.lastname: Sun
authors.forename: J A
authors.initials: JA
authors.lastname: Schafer
mesh_terms: D000818:Animals; D001127:Arginine Vasopressin / Q000502:physiology*; D001692:Biological Transport / Q000187:drug effects; D000242:Cyclic AMP / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D015259:Dopamine Agents / Q000494:pharmacology; D007672:Kidney Cortex; D007685:Kidney Tubules, Collecting / Q000187:drug effects / Q000378:metabolism*; D010539:Permeability / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000502:physiology*; D050638:Receptors, Dopamine D4; D012964:Sodium / Q000378:metabolism*; D014867:Water / Q000378:metabolism*
chemical_list: D015259:Dopamine Agents; C493601:Drd4 protein, rat; D017448:Receptors, Dopamine D2; D014867:Water; D001127:Arginine Vasopressin; D050638:Receptors, Dopamine D4; D003900:Desoxycorticosterone; D012964:Sodium; D000242:Cyclic AMP; D004298:Dopamine